Most importantly, they provide functional characterization of cells expressing these newly identified stromal markers within the colorectal cancer microenvironment, demonstrating that TASCs overexpressing CNN1 and TPM2 at protein level do directly support cancer progression by enhancing tumor cell proliferation, migration, and metastatic potential. The gene discussed is TPM2; the disease is colorectal cancer.